Peter Lederman in Second Bout With COVID-19

I guess this is all pure speculation, until the man himself informs us of his circumstances. He did take part in the thread highlighting the Covid-related issues that Soundsmith were contending with last Summer.
It'll be hugely reassuring if Peter recovers sufficiently to do the same this time around.

@bkeske, medical issues have a habit of getting twisted around even in the first person. Sometimes it is the doctors fault. They will frequently give a very shorthand explanation of what is going on and get miss understood. I usually do not get the full story until I get the notes from the hospital. Even then sometimes I remain confused.

Hospital care has taken a dive since the recruitment of hospitalists. The job of a hospitalist is to make money for the corporation. In metropolitan areas primary care physicians got locked out of hospitals.

The way they did it was in order to get inpatient privileges you had to have at least 20 inpatient cases a year. Very few of us have that many inpatient cases on a yearly basis. Many primary care physicians are happy with this as hospitals can be a PITA.You make more money with less work staying in your office.

The loser is as always the Patient. Medicine has become industrialized and impersonal. It's job is making money and not getting sued. Having been personally involved with "the best" hospitals in Boston on multiple occasions recently. I have had surgery 5 times in the last 2 years and each one was followed by complications, one a serious and iatrogenic osteomyelitis of my left clavicle which required 6 weeks of IV antibiotics and a bone graft from my right hip followed by an ilioinguinal neuropathy and a huge hematoma. I have fully recovered but am left with two steel plates and sixteen screws in my shoulder.

Yikes! So you have seen up close and personal what I have been talking about for some time now. I was there too last year and saw it myself.

Even after I got out and recovered and had enough energy to go back and try and let them know what happened, my "Patient Advocate" turned out to be a total corporate lackey, they flat out lied about things I know happened and it developed into a situation where I had to either give up or try and push a major federal case. Got a good life ahead of me, not about to devote it to trying to fix our broken health care system!  

It is well and truly broken. So broken that when I hear Peter is in hospital my first thought is not gee I hope whatever he has doesn't kill him, it's gee I hope "health care" doesn't kill him! I remember as a little kid the general attitude among people my parents age was oh no the hospital, is where people go to die! Medicine then made tremendous progress, thanks to science, only to swing back to the dark ages, thanks to financialization. 

The sooner he can get out of there the better. Godspeed.

"The sooner he can get out of there the better."

It took 13 lines to come up with this conclusion?

So I have been following this stock for over a year now..
It is actually gaining traction hurt by terrible PR..
There was a similar super positive account in Britain and now from the Philippines..Peter's Docs should investigate this..Please.

https://seekingalpha.com/news/3679216-cytodyn-updates-on-leronlimab-treated-covid-19-patient

Like some of the many discussants on the thread you cited, we can agree the case report is interesting, but it is one case. In response to the objection that the report is anecdotal , a few others noted that there were other successful individual case reports as well. Still other contributors implied that FDA is corrupt, because it won’t approve drugs like this with a few scattered reports of success, which by the way we don’t really know were successes. It could as well be the case that those patients who were receiving other treatment modalities would have recovered anyway. That is the problem. The FDA is bound to consider only data that arise from a controlled trial which is conducted according to a study plan that is submitted to FDA and approved by FDA prior to the start of the study. Furthermore there have to be safety precautions in place, and there has to be an independent data monitoring board that reviews adverse events and makes final judgment on clinical outcome. Apparently the company that makes this drug did submit some study data to FDA, and on the basis of those data, FDA did not see fit to issue an EUA. This drug was originally formulated and developed for treatment of HIV, because it blocks the CCR5 receptor on T lymphocytes which is an auxiliary receptor for HIV. I guess it could be useful in Covid because of possible activity in inhibiting cytokine storm via its putative effect on the immune response. Several other drugs with similar rationales for their use have been tried in late stage, severe cases of Covid, and some of them do show a modest benefit. But the operative word is modest. None of them is a magic bullet. None of them is even any better than dexamethasone, which is current standard of care. Certainly the CCR5 receptor has no biological role in the pathogenesis of Covid. So I am dubious that this drug will ever be a major success in this particular application.